LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.00021667
36.01 27.76 3101 2662 1.1645 1.0468
MN20160318_Q01
N21
MCF 10A-H2B-mCherry Trametinib
0.00021667
37.71 27.76 300 2877 0.1043 0.4269
MN20160318_Q01
G22
MCF 10A-H2B-mCherry Trametinib
0.00021667
37.71 27.76 2945 2877 1.0234 1.0069
MN20160318_Q01
G22
MCF 10A-H2B-mCherry Trametinib
0.00021667
37.71 27.76 320 2877 0.1112 0.4407
MN20160318_Q01
J19
MCF 10A-H2B-mCherry Trametinib
0.00021667
37.71 27.76 3779 2877 1.3132 1.0831
MN20160318_Q01
J19
MCF 10A-H2B-mCherry Trametinib
0.00021667
37.71 27.76 3572 2877 1.2413 1.0656
MN20160318_Q01
N10
MCF 10A-H2B-mCherry Trametinib
0.00021667
37.71 27.76 3661 2877 1.2722 1.0732
MN20160318_Q01
N10
MCF 10A-H2B-mCherry Trametinib
0.00021667
37.71 27.76 177 2877 0.0615 0.3188
MN20160318_Q01
N21
MCF 10A-H2B-mCherry Trametinib
0.00021667
37.71 27.76 3320 2877 1.1537 1.0432
MN20160318_Q01
N21
MCF 10A-H2B-mCherry Trametinib
0.00021667
39.41 27.76 324 3105 0.1043 0.4348
MN20160318_Q01
G22
MCF 10A-H2B-mCherry Trametinib
0.00021667
39.41 27.76 3157 3105 1.0165 1.0048
MN20160318_Q01
G22
MCF 10A-H2B-mCherry Trametinib
0.00021667
39.41 27.76 362 3105 0.1166 0.4584
MN20160318_Q01
J19
MCF 10A-H2B-mCherry Trametinib
0.00021667
39.41 27.76 4096 3105 1.3189 1.0830
MN20160318_Q01
J19
MCF 10A-H2B-mCherry Trametinib
0.00021667
39.41 27.76 3822 3105 1.2307 1.0619
MN20160318_Q01
N10
MCF 10A-H2B-mCherry Trametinib
0.00021667
39.41 27.76 3892 3105 1.2532 1.0674
MN20160318_Q01
N10
MCF 10A-H2B-mCherry Trametinib
0.00021667
39.41 27.76 213 3105 0.0686 0.3491
MN20160318_Q01
N21
MCF 10A-H2B-mCherry Trametinib
0.00021667
39.41 27.76 3616 3105 1.1643 1.0452
MN20160318_Q01
N21
MCF 10A-H2B-mCherry Trametinib
0.00021667
41.11 27.76 345 3331 0.1036 0.4403
MN20160318_Q01
G22
MCF 10A-H2B-mCherry Trametinib
0.00021667
41.11 27.76 3337 3331 1.0017 1.0005
MN20160318_Q01
G22
MCF 10A-H2B-mCherry Trametinib
0.00021667
41.11 27.76 450 3331 0.1351 0.4968
MN20160318_Q01
J19
MCF 10A-H2B-mCherry Trametinib
0.00021667
41.11 27.76 4390 3331 1.3177 1.0815
MN20160318_Q01
J19
MCF 10A-H2B-mCherry Trametinib
0.00021667
41.11 27.76 4125 3331 1.2382 1.0628
MN20160318_Q01
N10
MCF 10A-H2B-mCherry Trametinib
0.00021667
41.11 27.76 4202 3331 1.2613 1.0684
MN20160318_Q01
N10
MCF 10A-H2B-mCherry Trametinib
0.00021667
41.11 27.76 216 3331 0.0648 0.3459
MN20160318_Q01
N21
MCF 10A-H2B-mCherry Trametinib
0.00021667
41.11 27.76 3825 3331 1.1481 1.0404
MN20160318_Q01
N21